346 related articles for article (PubMed ID: 7524376)
41. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors.
Wick MR; Swanson PE; Rocamora A
J Cutan Pathol; 1988 Aug; 15(4):201-7. PubMed ID: 3053811
[TBL] [Abstract][Full Text] [Related]
42. Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings.
Aguirre P; Thor AD; Scully RE
Am J Clin Pathol; 1989 Aug; 92(2):140-9. PubMed ID: 2474244
[TBL] [Abstract][Full Text] [Related]
43. Immunostaining of human melanomas by a monoclonal antibody to B700 mouse melanoma antigen.
Xu X; Azumi N; Skelton HG; Hearing VJ; Gersten DM
Eur J Cancer; 1996 Jan; 32A(1):168-73. PubMed ID: 8695227
[TBL] [Abstract][Full Text] [Related]
44. KBA.62: a useful marker for primary and metastatic melanomas.
Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
[TBL] [Abstract][Full Text] [Related]
45. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.
Argenyi ZB; Cain C; Bromley C; Nguyen AV; Abraham AA; Kerschmann R; LeBoit PE
Am J Dermatopathol; 1994 Jun; 16(3):233-40. PubMed ID: 7943629
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical studies of conjunctival nevi and melanomas.
Jakobiec FA; Bhat P; Colby KA
Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
[TBL] [Abstract][Full Text] [Related]
47. An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.
Gatter KC; Ralfkiaer E; Skinner J; Brown D; Heryet A; Pulford KA; Hou-Jensen K; Mason DY
J Clin Pathol; 1985 Dec; 38(12):1353-7. PubMed ID: 3908491
[TBL] [Abstract][Full Text] [Related]
48. Signet-ring cell melanoma. A rare morphologic variant of malignant melanoma.
Sheibani K; Battifora H
Am J Surg Pathol; 1988 Jan; 12(1):28-34. PubMed ID: 2447807
[TBL] [Abstract][Full Text] [Related]
49. Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions.
Daste G; Serre G; Mauduyt MA; Vincent C; Caveriviere P; Soleilhavoup JP
Cytopathology; 1991; 2(1):19-28. PubMed ID: 1715202
[TBL] [Abstract][Full Text] [Related]
50. Expression of a glycoprotein of the carcinoembryonic antigen family in normal and neoplastic sebaceous glands. Limited role of carcinoembryonic antigen as a sweat gland marker.
Metze D; Soyer HP; Zelger B; Neumaier M; Grunert F; Hartig C; Amann U; Bhardwaj R; Wagener C; Luger T
J Am Acad Dermatol; 1996 May; 34(5 Pt 1):735-44. PubMed ID: 8632066
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical analysis of salivary gland canalicular adenoma.
Ferreiro JA
Oral Surg Oral Med Oral Pathol; 1994 Dec; 78(6):761-5. PubMed ID: 7534898
[TBL] [Abstract][Full Text] [Related]
53. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
Spanknebel K; Coit DG; Bieligk SC; Gonen M; Rosai J; Klimstra DS
Am J Surg Pathol; 2005 Mar; 29(3):305-17. PubMed ID: 15725798
[TBL] [Abstract][Full Text] [Related]
54. Expression of melanoma antigens in epithelioid gastrointestinal stromal tumors: a potential diagnostic pitfall.
Guler ML; Daniels JA; Abraham SC; Montgomery EA
Arch Pathol Lab Med; 2008 Aug; 132(8):1302-6. PubMed ID: 18684030
[TBL] [Abstract][Full Text] [Related]
55. SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions.
Trefzer U; Rietz N; Chen Y; Audring H; Herberth G; Siegel P; Reinke S; Königer P; Wu S; Ma J; Liu Y; Wang H; Sterry W; Guo Y
Arch Dermatol Res; 2000 Dec; 292(12):583-9. PubMed ID: 11214818
[TBL] [Abstract][Full Text] [Related]
56. Primary cutaneous PEComa: distinctive clear cell lesions of skin.
Liegl B; Hornick JL; Fletcher CD
Am J Surg Pathol; 2008 Apr; 32(4):608-14. PubMed ID: 18277881
[TBL] [Abstract][Full Text] [Related]
57. Is MAGE-1 expression in metastatic malignant melanomas really helpful?
Gajjar NA; Cochran AJ; Binder SW
Am J Surg Pathol; 2004 Jul; 28(7):883-8. PubMed ID: 15223957
[TBL] [Abstract][Full Text] [Related]
58. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
Jungbluth AA; Busam KJ; Gerald WL; Stockert E; Coplan KA; Iversen K; MacGregor DP; Old LJ; Chen YT
Am J Surg Pathol; 1998 May; 22(5):595-602. PubMed ID: 9591730
[TBL] [Abstract][Full Text] [Related]
59. Comparative study of carcinoembryonic antigen and epithelial membrane antigen expression in normal colon, adenomas and adenocarcinomas of the colon and rectum.
Davidson BR; Sams VR; Styles J; Dean C; Boulos PB
Gut; 1989 Sep; 30(9):1260-5. PubMed ID: 2806995
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemistry of ovarian granulosa cell tumours. The value of tissue specific proteins and tumour markers.
Chadha S; van der Kwast TH
Virchows Arch A Pathol Anat Histopathol; 1989; 414(5):439-45. PubMed ID: 2471350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
